Skip Nav Destination
Refining genetic stratification in T-ALL
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival
Issue Archive
January 18 2018
Table of Contents
BLOOD COMMENTARIES
CLINICAL TRIALS AND OBSERVATIONS
Refining genetic stratification in T-ALL
Clinical Trials & Observations
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia
CME
Clinical Trials & Observations
Arnaud Petit,Amélie Trinquand,Sylvie Chevret,Paola Ballerini,Jean-Michel Cayuela,Nathalie Grardel,Aurore Touzart,Benoit Brethon,Hélène Lapillonne,Claudine Schmitt,Sandrine Thouvenin,Gerard Michel,Claude Preudhomme,Jean Soulier,Judith Landman-Parker,Guy Leverger,Elizabeth Macintyre,André Baruchel,Vahid Asnafi,on behalf of the French Acute Lymphoblastic Leukemia Study Group (FRALLE)
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
Clinical Trials & Observations
Thierry Facon,Meletios A. Dimopoulos,Angela Dispenzieri,John V. Catalano,Andrew Belch,Michele Cavo,Antonello Pinto,Katja Weisel,Heinz Ludwig,Nizar J. Bahlis,Anne Banos,Mourad Tiab,Michel Delforge,Jamie D. Cavenagh,Catarina Geraldes,Je-Jung Lee,Christine Chen,Albert Oriol,Javier De La Rubia,Darrell White,Daniel Binder,Jin Lu,Kenneth C. Anderson,Philippe Moreau,Michel Attal,Aurore Perrot,Bertrand Arnulf,Lugui Qiu,Murielle Roussel,Eileen Boyle,Salomon Manier,Mohamad Mohty,Herve Avet-Loiseau,Xavier Leleu,Annette Ervin-Haynes,Guang Chen,Vanessa Houck,Lotfi Benboubker,Cyrille Hulin
GENE THERAPY
HEMATOPOIESIS AND STEM CELLS
MYELOID NEOPLASIA
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
Hui Yang,Stefan Kurtenbach,Ying Guo,Ines Lohse,Michael A. Durante,Jianping Li,Zhaomin Li,Hassan Al-Ali,Lingxiao Li,Zizhen Chen,Matthew G. Field,Peng Zhang,Shi Chen,Shohei Yamamoto,Zhuo Li,Yuan Zhou,Stephen D. Nimer,J. William Harbour,Claes Wahlestedt,Mingjiang Xu,Feng-Chun Yang
RED CELLS, IRON, AND ERYTHROPOIESIS
Ferritin is secreted via 2 distinct nonclassical vesicular pathways
Marianna Truman-Rosentsvit,Dina Berenbaum,Lior Spektor,Lyora A. Cohen,Shirly Belizowsky-Moshe,Lena Lifshitz,Jing Ma,Wei Li,Ellina Kesselman,Inbal Abutbul-Ionita,Dganit Danino,Lucia Gutierrez,Huihui Li,Kuanyu Li,Huifang Lou,Maria Regoni,Maura Poli,Fabian Glaser,Tracey A. Rouault,Esther G. Meyron-Holtz
VASCULAR BIOLOGY
LETTERS TO BLOOD
Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis
Clinical Trials & Observations
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival
Clinical Trials & Observations
BLOOD WORK
ERRATUM
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
-
Cover Image
Cover Image
Fluorescence microscopy image of ferritin (green) and the Golgi marker GM-130 (red) in murine macrophages treated with brefeldin A, an agent that disrupts the Golgi structure. See the article by Truman-Rosentsvit et al on page 342.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals